Chimeric antigen receptor-modified T cells induce partial remission in first AML patient treated Dec. 14, 2015
DMC recommends continuation of phase III trial of AGS-003 in RCC following second interim analysis Dec. 14, 2015
IL-15N72D/IL-15Ralpha-Fc superagonist complex shows promise for high-risk hematologic malignancies Dec. 9, 2015
RSS